Slideshow

6 New Drugs for Neurologists

Author(s):

Newly approved medications for various types of pain, generalized myasthenia gravis, and Parkinson disease will be fodder for discussion at AAN 2018. Here’s a brief overview of the therapies the FDA has approved within the past 6 months.

Newly approved treatments for several neurologic disorders-including various types of pain, generalized myasthenia gravis, and Parkinson Disease-will be topics of discussion at AAN 2018. Here’s a brief overview of those medications FDA approved within the past 6 months.

Newsletter

Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.

Related Videos
Laren Becker, MD, PhD
David Shprecher, DO, MSci, FAAN
Pamela Zeilman, NP
 Esther Labib-Kiyarash, MSHA, CPHQ
Justin Martello, MD
William Ondo, MD
Jennifer Corcoran, MD
Marcia Pasqualini, PhD
Anissa Mitchell, LCSW
Daniel Irizarry, MD
© 2025 MJH Life Sciences

All rights reserved.